Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
SDF-1/CXCR4 signaling preserves microvascular integrity and renal function in chronic kidney disease
GLP-/GIP dual agonist innovatively integrates the effects of two incretin into one molecule, which can simultaneously activate GLP-1R and GIPR
Gellmans company Longevity Biotech now has a drug candidate that activates both GLP-1 and GIP, is biased towards the insulin signalling pathway and can be orally formulated
Productora: Sptima Ars
It may also increase the risk of low blood sugar when used with other diabetes medications
US$ 28.30
US$ 23.87
:max_bytes(150000):strip_icc()/VWH-GettyImages-1469751146-5eff6dd0b38449ff9dca9313c7c393d5.jpg)
US$ 25.28
